RNS Number : 7957C
BrainJuicer Group PLC
05 September 2008
 




PresRelease 

5 September 2008


BrainJuicer Group PLC

("BrainJuicer" or "the Company")


Interim Results for the Six Months ended 30 June 2008

Reported under IFRS


BrainJuicer Group PLC (AIM: BJU), a leading international online market research agency, today announces its Interim Results for the six months ended 30 June 2008.


Highlights

Significant top-line organic growth with revenue up by 37% to £3,970,000 (2007: £2,901,000)
Operating profit increased by 33% to £196,000 (2007: £147,000)
Profit after tax increased by 42% to £161,000 (2007: £113,000)
Maiden interim dividend of 0.5p per share declared
Additional special dividend of 1.7p per share declared
Increased major client base to 19 of the world’s top 200 companies
(source: FT 2008 Global 500 listing), and a further 32 blue-chip clients
72% of revenue from repeat business
Strong uptake of innovative new products – Predictive Markets, CommScanTM, Insight ValidationTM and Creative 6ersTM – up 47% from £1,237,000 for the first 6 months of 2007 to £1,818,000 for the same period in 2008
Broadening geographic reach:
US – the world’s largest research market – firmly established with revenues up 246% over the same period in 2007 and rapidly growing base of blue-chip clients;
Switzerland – location of many European Head Offices - new office opened in June 2008;
Australia – location of many Far East Head Offices - entered into Australian market with Slater Marketing licensing agreement

 


Commenting on the results, John Kearon, Chief Executive of BrainJuicer Group PLC, said: "During 2008 we have continued to build our business, focusing on our innovation, technology and provision of commercially valuable Insights to our clients. The Board has been pleased with the Company's progress so far this year. We have had another period of strong organic growth, a significantly increased list of satisfied blue-chip clients, and a broadening strategic geographic footprint. 

"To support BrainJuicer's underlying growth, we are continuing to invest. Our team has increased from 48 at the end of 2007, to 64 at 30 June 2008, 58% of which are client facing. The Company's innovative, new products are gaining traction, and now comprise 46% of turnover, demonstrating the continued success of our BrainJuicer Labs innovation programme. We are pleased to be announcing our maiden interim dividend, which reflects the Company's success during the period, and are excited about the Company's future prospects as we expand geographicallycontinue to innovate, and build profitable relationships with the world's largest buyers of market research."


For further information, please contact:


BrainJuicer Group PLC

Tel: +44 (0)20 7043 1000

John Kearon, Chief Executive Officer

john.kearon@brainjuicer.com


James Geddes, Chief Financial Officer

james.geddes@brainjuicer.com



Landsbanki Securities (UK) Limited

Tel: +44 (0)20 7426 9000

Fred Walsh / Simon Brown



Media enquiries:

Abchurch Communications

Tel: +44 (0)20 7398 7700

Heather Salmond / Joanne Shears / Jack Ballantyne

jack.ballantyne@abchurch-group.com


  Chief Executive Officer's Statement


Introduction

The Board is pleased to report that the Company has continued to make good progress during the period, with strong organic growth so far in 2008.  The Company has not suffered from  any softening in the marketand is well placed to capitalise on the industry's continued shift  from offline to online market research.  We continue to placsignificant emphasis on  product  innovation, technologdevelopment and the provision of commerciallvaluable insightsto  manof  the world's biggest buyers of market research.  


Financial Performance

Revenue for the half-year increased by 37% to £3,970,000 (2007: £2,901,000), with gross margin continuing at levels of over 70%.  Operating costs increased from £2,021,000 in the first half of 2007 to £2,801,000 this year as the Company continued to build its team.  Headcount increased from 48 at the end of 2007 to 64 at the end of June 2008. This increase is predominantly in client facing roles, and positions the business for further significant top-line growth.


Operating profit rose from £147,000 in the first half of 2007 to £196,000 this year (an increase of 33%), and profit after taxation rose from £113,000 to £161,000 (up 42%).   Earnings peshare increased from 0.9p in the first half of 2007 to 1.3pand fully diluted earnings  peshare increased from 0.9p to 1.2p.


The Company generated £579,000 cash from its operations and invested £304,000 on capital  expenditure (predominantly IT equipment and its software technology platform). It ended the period with a cash balance of £2,128,000, up from £1,875,000 at 31 December 2007. The Company has no debt.


The Board has decided that the Company is in a position to begin paying dividends, and intends to pay an interim dividend of 0.5peshare.  The Company is aiming to maintain a progressive dividend policy.  The board has further decided that, given the Company's strong balance sheet  and cash generation it is able to return an additional amount to shareholders at this time. It therefore plans on making a special, one-off, dividend payment of 1.7p peshare.  The total of the  interim dividend and the special dividend is a payment of 2.2p peshare.  The payments will be  made on 14 October 2008 to shareholders on the register on 19 September 2008 (the record date). The ex-dividend date will be 17 September 2008.


Operations

The Company continued to grow its core UK business profitably, with revenue growth of 43%,  serving a broad spread of multinational and blue-chip domestic clients from its well established London-based account management team.


The Company has also broadened its geographic reach. In Continental Europe, the Company has supplemented its Dutch position with a move into Switzerland, where a high number of  global companies have theiEuropean heaoffices.  The Dutch office experienced a small decline in revenue due to the cyclical spending patterns of the Company's largest Dutch client.


The Company's US position is establishing itself well. This is the most competitive research  market in the world, yet our US business grew very strongly with revenue up 246%, from a well-balanced mix of new and existing clients.  BrainJuicer is pleased to be making significant inroads into very large companies in this territory and has succeeded in differentiating itself within a crowded marketwith its distinctive products


Further afield, the Company has also entered the Australian market via a licence arrangement with a long establisheMelbourne based agency (Slater Marketing).  The Company may acquire Slater subject to certain performance conditions.


Innovation

The Company's main focusand its core strength, is in innovation, particularly in developing  research techniques which address the difficult and highly strategic early phases of clients' product development cycles.  The Company's four pioneering techniques, Predictive Markets (which won  the ESOMAR Best Methodologaward in 2006), CommScanTM (utilising FaceTraceTM,  which won the ESOMAR Best Methodologaward in 2007), Insight ValidationTM and Creative 6ersTM, grew by 47% over the first six months of this year compared to the samperiod last yearand  now comprise 46% of the Company's revenue.


Clients

BrainJuicer's clients are mainly large consumer-facing companies, who are the largest research buyers in the world. The Company is continually striving to deepeits relationships with its existing clients It has a teaof high level and experienced market research professionals, who above  all else, endeavour to exceed expectations on each and every project they undertake.  Repeat  business is high; during the first half of the year72of revenue was from existing clients, and the average project size increased 10% to £15,881 per project (2007: £14,442).


The Company has also undertaken considerable new business development efforts, and hired an  experienced senior sales and marketing executive, based in the US. During the first half of the year, the Company won business from 32 new significant clients, predominantly in the US, the largest  and most advanced market in which BrainJuicer operates. The Company now has 137 clients, and  serves 19 of the world's 200 largest companies.


Technology

The Company continues to invest in its proprietary technology platform to improve the efficiency in which it delivers its projects. Average revenue peheadcount in the period has been maintained after the heavy increase in new staff (£70,893 compared to £70,756 during the samperiod last year).


Outlook

The Board is confident that the Company has a competitive, simple, and proven model that can continue to be rolled out to strategic geographies, in profitable, revenue led, low investment  manner, and plans to continue to gain strategic geographic coverage to meet the needs of its multinational client base. Whilst new offices do dilute profit margins initially, the Board believes there is a relatively short pay-back, and the anticipated strategic benefits are significant. The Company's strong position within the market gives the Board confidence in BrainJuicer's ability to deliver  sustainable and profitable growth.



John Kearon
Chief Executive Officer


CONDENSED CONSOLIDATED INCOME STATEMENT FOR SIX MONTHS ENDED 30 JUNE 2008




Note


Six months ended

30 June 2008

Unaudited

Six months ended

30 June 2007

Unaudited

Year ended 31 December 2007

Audited



£'000

£'000 

£'000






Revenue


3,970

2,901

6,566

Cost of sales


(973)

(733)

(1,727)






Gross profit


2,997

2,168

4,839

Administrative expenses


(2,801)

(2,021)

(3,995)






Operating profit


196

147

844

Investment income


33

17

49






Profit before taxation


229

164

893

Income tax expense

6

(68)

(51)

(233)






Profit for the financial year


161

113

660






Attributable to equity holders of the Company


161

113

660






Earnings peshare attributable 

to the equity holders of the Company





Basic earnings peshare

7

1.3p

0.9p

5.2p






Diluted earnings peshare

7

1.2p

0.9p

5.0p



All of the activities of the Group are classed as continuing.  

  CONDENSED CONSOLIDATED BALANCE SHEET AS AT 30 JUNE 2008


 
 
 
 30 June 2008
Unaudited
30 June 2007
Unaudited
31 December 2007
Audited
 
 
£’000
£’000
£’000
ASSETS
 
 
 
 
Non-current assets
 
 
 
 
Property, plant and equipment
 
187
89
119
Intangible assets
4
425
119
328
Financial assets – available for sale investments
 
85
-
-
Deferred tax asset
 
226
322
222
 
 
923
530
669
Current assets
 
 
 
 
Inventories
 
32
27
16
Trade and other receivables
 
1,872
1,677
2,630
Cash and cash equivalents
 
2,128
1,319
1,875
 
 
4,032
3,023
4,521
Total assets
 
4,955
3,553
5,190
 
 
 
 
 
EQUITY
 
 
 
 
Capital and reserves attributable to equity holders of the Company
 
 
 
 
Share capital
9
126
126
126
Share premium account
 
1,411
1,399
1,408
Merger reserve
 
477
477
477
Foreign currency translation reserve
 
102
1
51
Other reserve
 
304
336
278
Retained earnings
 
581
(145)
412
Total equity
 
3,001
2,194
2,752
 
 
 
 
 
LIABILITIES
 
 
 
 
Current liabilities
 
 
 
 
Trade and other payables
 
1,570
1,001
2,092
Current income tax liabilities
 
384
250
346
Financial liabilities
 
-
108
-
Total liabilities
 
1,954
1,359
2,438
 
 
 
 
 
Total equity and liabilities
 
4,955
3,553
5,190






CONDENSED CONSOLIDATED CASH FLOW STATEMENT FOR SIX MONTHS ENDED 
30 JUNE 2008





 30 June 2008

Unaudited

30 June 2007

Unaudited

31 December 2007

Audited



£'000 

£'000 

 

£'000






Net cash generated from operations


579

208

1,173

Tax paid


(58)

-

(77)

Net cash generated from operating activities


521

208

1,096






Cash flows used by investing activities





Purchaseof property, plant and equipment


(109)

(29)

(83)

Purchaseof intangible assets


(110)

(119)

(330)

Purchase of available for sale financial assets


(85)

-

-

Interesreceived


33

17

49

Net cash used by investing activities


(271)

(131)

(364)






Cash flows generated from / (used by) financing activities





Proceeds from other issue of ordinary shares


3

9

18

Repayment of financial liabilities


-

-

(108)

Net cash generated from / (used by) financing activities


3

9

(90)






Net increase in cash and cash equivalents  


253

86

642






Cash and cash equivalents at beginning of period


1,875

1,233

1,233






Cash and cash equivalents at end of period


2,128

1,319

1,875










CONDENSED CONSOLIDATED STATEMENT OF CHANGES IN EQUITY AS AT 

30 JUNE 2008



 
Share capital
Share premium account
Merger reserve
Foreign currency translation reserve
Other reserve
Retained earnings
Total
 
£’000
£’000
£’000
£’000
£’000
£’000
£’000
 
 
 
 
 
 
 
 
Balance at 1 January 2007
126
1,390
477
(5)
255
(277)
1,966
 
 
 
 
 
 
 
 
Exchange differences on consolidation
-
-
-
6
-
-
6
Profit for the period
-
-
-
-
-
113
113
Total income recognised for the   period
 
-
 
-
 
-
 
6
 
-
 
113
 
119
Exercise of share options
-
9
-
-
(1)
19
27
Deferred tax credited to equity
-
-
-
-
55
-
55
Share-based payment charge
-
-
-
-
27
-
27
 
-
9
-
6
81
132
228
Balance at 30 June 2007
126
1,399
477
1
336
(145)
2,194
 
 
 
 
 
 
 
 
Balance at 1 January 2008
 126
1,408
477
51
278
412
2,752
 
 
 
 
 
 
 
 
Exchange differences on consolidation
-
-
-
51
-
-
51
Profit for the period
-
-
-
-
-
161
161
Total income recognised for the period
-
-
-
51
-
161
212
Exercise of share options
-
3
-
-
 
8
11
Deferred tax debited to equity
-
-
-
-
(29)
-
(29)
Share-based payment charge
-
-
-
-
55
-
55
 
-
3
-
51
26
169
249
At 30 June 2008
126
1,411
477
102
304
581
3,001
 
 
 
 
 
 
 
 
 
 


   

1.

General information


BrainJuicer Group plc ("the Company"), a United Kingdom resident, and its subsidiaries (together "the Group") provide on-line market research services. The Company's shares are listed on the Alternative Investment Market of the London Stock Exchange ("AIM").  The address of the Company's registered office is 13-14 Margaret StreetLondonW1W 8RN.


The condensed consolidated interim financial information was approved by the board  of directors on 5 September 2008.


2.

Basis of preparation


The condensed interim financial information for the half year ended 30 June 2008 has been prepared in accordance with IAS 34 'Interim financial reporting'. The interim condensed financial report should be read in conjunction with the annual financial statements for the year ended 31 December 2007.


The condensed consolidated financial information has been prepared under the historical cost convention.



3.

Principal accounting policies


Except as described below, the principal accounting policies adopted are consistent with those of the annual financial statements for the year ended 31 December 2007.


The following accounting policy was adopted during the period.


Financial assets - available-for-sale financial assets


'Available-for-sale' financial assets include all financial assets other than derivatives, loans  and receivables.  They are classified as non-current unless management intend to dispose of  the investment within 12 months of the balance sheet date.


Investments are initiallrecorded in the balance sheet at fair value plus transaction costs, unless the asset is held for trading, in which case the transaction cost is expensed in the income statementFinancial assets are derecognised when the rights to receive cash flows from the investments have expired or have been transferred and the group has transferred  substantiallall risks and rewards of ownership. Available-for-sale financial assets are  subsequently carried at fair value.  


The fair values of quoted investments are based on current bid prices. If the market for a financial asset is not active (or the financial asset is an unlisted security), the Group establishefair value by reference to other recent comparable arm's length transactions or  other quoted instruments that are substantially the same, and, or, by discounted cash flow analysis.


The group assesses at each balance sheet date whether there is objective evidence that a financial asset or a group of financial assets is impaired. In the case of equity securities classified as available-for-sale, a significant or prolonged decline in the fair value of the security below its cost is considered as an indicator that the securities are impaired. If any such evidence exists for available-for-sale financial assets, the cumulative loss - measured as the difference between the acquisition cost and the current fair value - is removed from equity and recognised in the income statement. Impairment losses recognised in the income statement on equity instruments are not reversed through the income statement.




4.

Available-for-sale financial assets


During the period the group acquired an interesof 3.64% in Slater Marketing Pty Limited, an unlistecompany incorporated in Australia, for cash consideration of £40,000 plus  transaction costs of £45,000. 

The investment has been classified as an available-for-sale financial asset. Subject to certain performance conditions the group may acquire the remaining equity share  capital of Slater Marketing Pty Limited.


5.

Segment information


The Group operates in one business segment, that of market research.  Whilst there are a number of products within the business segment, management reporting is principally based on location of service delivery.  Accordingly the Group presents its primary segment analysis on this basis:  

 

Six months ended 30 June 2008
 
 
 
 
 
United Kingdom
Continental
Europe
Rest of the World
 
Group
Total
 
£’000
£’000
£’000
£’000
£’000
 
 
 
 
 
 
Total segment revenue
2,553
965
452
-
3,970
Inter segment revenue
-
-
-
-
-
Segment revenue
2,553
965
452
-
3,970
 
 
 
 
 
 
Segment operating profit
619
353
(49)
(727)
196
 
 
 
 
 
 


Six months ended 30 June 2007
 
 
 
 
 
United Kingdom
Continental 
Europe
Rest of the World
 
Group
Total
 
£’000
£’000
£’000
£’000
£’000
 
 
 
 
 
 
Total segment revenue
1,837
934
146
-
2,917
Inter segment revenue
(16)
-
-
-
(16)
Segment revenue
1,821
934
146
-
2,901
 
 
 
 
 
 
Segment operating profit
576
309
(155)
(583)
147
 
 
 
 
 
 


Year ended 31 December 2007
 
 
 
 
 
United Kingdom
Continental 
Europe
Rest of the World
 
Group
Total
 
£’000
£’000
£’000
£’000
£’000
 
 
 
 
 
 
Total segment revenue
4,209
1,955
429
-
6,593
Inter segment revenue
(27)
-
-
-
(27)
Segment revenue
4,182
1,955
429
-
6,566
 
 
 
 
 
 
Segment operating profit
1,431
966
(194)
(1,359)
844
 
 
 
 
 
 


Group costs include directors' remuneration and central costs which are not directly attributable to geographic segments.  

  

6.

Income tax expense




Six months ended

30 June 

2008

Unaudited

Six months ended

30 June 2007

Unaudited

Year ended 31 December 2007

Audited


£'000

£'000

£'000





Current tax

92

106

269

Deferred tax

(24)

(55)

(36)


68

51

233





Income tax expense for the period differs from the standard rate of taxation as follows:








Profit on ordinary activities before taxation

229

164

893

Profit on ordinary activities multiplied by standard rate of taxation of 28% (2007: 30%)

64

49

268





Difference between tax rates applied to Group's subsidiaries

(5)

(1)

(28)

Expenses not deductible for tax purposes

28

8

21

Other temporary differences

-

(5)

4

Re-measurement of deferred tax - change in UK tax rate

-

-

(14)

Adjustment to current tax in respect of prior periods

(19)

-

(18)

Total tax 

68

51

233


  

7.

Earnings per share


(a)

Basic


Basic earnings per share is calculated by dividing the profit attributable to equity holders of the Company by the weighted average of ordinary shares in issue during the period.




Six months ended

30 June 2008

Unaudited

Six months ended

30 June 2007

Unaudited

Year ended 31 December 2007

Audited


£'000

£'000

 

£'000





Profit attributable to equity holders of the Company 

161

113

660





Weighted average number of ordinary shares in issue

12,606,826

12,560,516

12,564,831





Basic earnings per share

1.3p

0.9p

5.2p


(b)

Diluted


Diluted earnings per share is calculated by adjusting the weighted average number of shares outstanding to assume conversion of all dilutive potential ordinary shares.  For share options, a calculation is made in order to determine the number of shares that could have been acquired at fair value (determined as the average annual market share price of the Company's shares) based on the monetary value of the subscription rights attached to outstanding share options.  The number of shares calculated in this way is compared with the number of shares that would have been issued assuming the exercise of the share options.  



Six months ended

30 June 2008

Unaudited

Six months ended

30 June 2007

Unaudited

Year ended 31 December 2007

Audited


£'000

£'000

£'000





Profit attributable to equity holders of the Company used to determine diluted earnings per share

161

113

660





Weighted average number of ordinary shares in issue

12,606,826

12,560,516

12,564,831

Share options

573,040

689,320

656,047

Weighted average number of ordinary shares for diluted earnings per share

13,179,866

13,249,836

13,220,878





Diluted earnings per share

1.2p

0.9p

5.0p

  

8.

Cash generated from operations




Six months ended

30 June 2008

Unaudited

Six months ended

30 June 2007

Unaudited

Year ended 31 December 2007

Audited


£'000 

£'000 

£'000





Profit before taxation

229

164

893

Depreciation and amortisation

57

17

45

Net finance costs

(33)

(17)

(49)

Share-based payment expense

55

27

54

(Increase) / decrease in inventory

(16)

18

29

Decrease / (increase) in receivables

758

(65)

(1,018)

(Decrease) / increase in payables

(522)

58

1,148

Exchange differences

51

6

71

Net cash generated from operations

579

208

1,173


9.

Share capital


During the period, share options over 25,000 ordinary shares were exercised at an exercise price of 11.4 pence per share. The total proceeds were £2,854, of which £250 was recognised as share capital, and £2,604 as share premium.

On 13 March 2008222,635 share options were granted to Directors and employees with an exercise price set at the market price on the date of grant (147.5 pence per share).



This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IR FKQKDABKDPCK